UPC Roundup (1 week): CoA says generic reference is not leave to appeal; CD Milan revokes remdesivir-related patent; and more

Sections 2.1, 2.2, 3.1, 4, 6.1, 6.2, 7, and 8 of this UPC Roundup were contributed by Mehnaz Khatoon.

This is a summary of developments in and around the Unified Patent Court (UPC) in the calendar week of May 4, 2026.

To Read The Full Story

Continue reading your article with a Membership